Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing zidovudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zidovudine adverse reaction |
Causative agent (attribute) |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to zidovudine (finding) |
Causative agent (attribute) |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zidovudine 100 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zidovudine 250mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zidovudine 50mg/5mL syrup (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
zidovudine 10 mg/mL, flacon de 20 mL pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zidovudine 200mg/20mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zidovudine 10mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lamivudine + zidovudine 150mg/300mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Azidothymidine measurement |
Component |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Abacavir sulfate + lamivudine + zidovudine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lamivudine + zidovudine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing lamivudine and zidovudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Abacavir- and lamivudine- and zidovudine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Lamivudine- and nevirapine- and zidovudine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zidovudine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zidovudine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely zidovudine 60 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lamivudine 30 mg and zidovudine 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to zidovudine (finding) |
Causative agent (attribute) |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to zidovudine (finding) |
Causative agent (attribute) |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Anemia caused by zidovudine (disorder) |
Causative agent (attribute) |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Lamivudine- and zidovudine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Zidovudine 100 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zidovudine 100 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zidovudine 250mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zidovudine 250mg capsule (substance) |
Has basis of strength substance (attribute) |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 30 mg and zidovudine 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 30 mg and zidovudine 60 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely zidovudine 60 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely zidovudine 60 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Abacavir- and lamivudine- and zidovudine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
Has precise active ingredient |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine 30 mg and zidovudine 60 mg oral tablet |
Has precise active ingredient |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely zidovudine 60 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zidovudine 100 mg oral capsule |
Has precise active ingredient |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zidovudine 250mg capsule (substance) |
Has precise active ingredient |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zidovudine 10 mg/mL oral solution |
Has precise active ingredient |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zidovudine 10 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only abacavir and lamivudine and zidovudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only abacavir and lamivudine and zidovudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only zidovudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lamivudine and nevirapine and zidovudine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only lamivudine and zidovudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only lamivudine and nevirapine and zidovudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only lamivudine and zidovudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only zidovudine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only zidovudine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet |
Has precise active ingredient |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Abacavir (as abacavir sulfate) 300 mg and lamivudine 150 mg and zidovudine 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
Has precise active ingredient |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Lamivudine 30 mg and zidovudine 60 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lamivudine 30 mg and zidovudine 60 mg oral tablet |
Has precise active ingredient |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Zidovudine 10 mg/mL solution for infusion |
Has precise active ingredient |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Zidovudine 10 mg/mL solution for infusion |
Has basis of strength substance (attribute) |
True |
Zidovudine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |